SCYNEXIS, Inc. (SCYX) Press Releases https://ir.scynexis.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/scynexis/files/theme/images/logo-sm.png SCYNEXIS, Inc. Logo Equisolve Investor Relations Suite <![CDATA[SCYNEXIS Announces $40.0 Million Private Placement]]> https://ir.scynexis.com/news-events/press-releases/detail/361/scynexis-announces-40-0-million-private-placement Tue, 31 Mar 26 06:45:00 -0400 https://ir.scynexis.com/news-events/press-releases/detail/361/scynexis-announces-40-0-million-private-placement <![CDATA[SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)]]> https://ir.scynexis.com/news-events/press-releases/detail/360/scynexis-completes-transformative-acquisition-of-pxl-770 Tue, 31 Mar 26 06:40:00 -0400 https://ir.scynexis.com/news-events/press-releases/detail/360/scynexis-completes-transformative-acquisition-of-pxl-770 <![CDATA[SCYNEXIS Reports Full Year 2025 Financial Results and Provides Corporate Update]]> https://ir.scynexis.com/news-events/press-releases/detail/359/scynexis-reports-full-year-2025-financial-results-and Wed, 04 Mar 26 16:20:00 -0500 https://ir.scynexis.com/news-events/press-releases/detail/359/scynexis-reports-full-year-2025-financial-results-and <![CDATA[SCYNEXIS Announces First Participants Dosed in a Phase 1 Single Ascending Dose and Multiple Ascending Dose Trial of Intravenous SCY-247]]> https://ir.scynexis.com/news-events/press-releases/detail/358/scynexis-announces-first-participants-dosed-in-a-phase-1 Thu, 26 Feb 26 08:23:00 -0500 https://ir.scynexis.com/news-events/press-releases/detail/358/scynexis-announces-first-participants-dosed-in-a-phase-1 <![CDATA[SCYNEXIS Announces Presentations Highlighting the Potent Antifungal Activity of its Second-Generation Fungerp, SCY-247 Against Drug-Resistant Fungi, at the Inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)]]> https://ir.scynexis.com/news-events/press-releases/detail/357/scynexis-announces-presentations-highlighting-the-potent Wed, 28 Jan 26 08:00:00 -0500 https://ir.scynexis.com/news-events/press-releases/detail/357/scynexis-announces-presentations-highlighting-the-potent <![CDATA[SCYNEXIS Receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations for SCY-247]]> https://ir.scynexis.com/news-events/press-releases/detail/356/scynexis-receives-fda-qualified-infectious-disease-product Wed, 21 Jan 26 08:00:00 -0500 https://ir.scynexis.com/news-events/press-releases/detail/356/scynexis-receives-fda-qualified-infectious-disease-product <![CDATA[SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement]]> https://ir.scynexis.com/news-events/press-releases/detail/355/scynexis-granted-180-day-extension-by-nasdaq-to-regain Mon, 22 Dec 25 08:00:00 -0500 https://ir.scynexis.com/news-events/press-releases/detail/355/scynexis-granted-180-day-extension-by-nasdaq-to-regain <![CDATA[SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK]]> https://ir.scynexis.com/news-events/press-releases/detail/354/scynexis-completes-transfer-of-brexafemme-new-drug Wed, 19 Nov 25 07:00:00 -0500 https://ir.scynexis.com/news-events/press-releases/detail/354/scynexis-completes-transfer-of-brexafemme-new-drug <![CDATA[Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections]]> https://ir.scynexis.com/news-events/press-releases/detail/353/scynexis-announces-federal-funding-of-collaboration-between Mon, 17 Nov 25 10:15:00 -0500 https://ir.scynexis.com/news-events/press-releases/detail/353/scynexis-announces-federal-funding-of-collaboration-between <![CDATA[SCYNEXIS Reports Third Quarter 2025 Financial Results and Provides Corporate Update]]> https://ir.scynexis.com/news-events/press-releases/detail/352/scynexis-reports-third-quarter-2025-financial-results-and Wed, 05 Nov 25 16:20:00 -0500 https://ir.scynexis.com/news-events/press-releases/detail/352/scynexis-reports-third-quarter-2025-financial-results-and